All are antiplatelet drugs except:
First, I should recall common antiplatelet drugs. The main ones are aspirin, clopidogrel, ticagrelor, prasugrel, and maybe dipyridamole. Then there are others like abciximab, eptifibatide, which are GPIIb/IIIa inhibitors. Also, cilostazol is another one. Now, if the options include a drug that's not in this list, that's the answer. Common non-antiplatelet drugs might be anticoagulants like warfarin, heparin, or direct oral anticoagulants (DOACs), or maybe something else like NSAIDs (but aspirin is an antiplatelet). Or perhaps a drug that's antiplatelet but not commonly used, or maybe a drug with a different mechanism.
Wait, the user's correct answer is C, so the options must have had a drug that's not antiplatelet. Let me think of possible distractors. For example, if option C is warfarin, which is an anticoagulant, not antiplatelet. Or maybe a drug like tirofiban, which is a GPIIb/IIIa inhibitor and is antiplatelet. So if the options were A: Aspirin, B: Clopidogrel, C: Warfarin, D: Ticagrelor, then the correct answer is C. That makes sense. So the core concept is distinguishing between anticoagulants and antiplatelet agents. The clinical pearl would be to remember that antiplatelet drugs inhibit platelet aggregation, whereas anticoagulants affect clotting factors.
Now, structuring the explanation. The core concept is the classification of antithrombotic drugs. Antiplatelet drugs prevent platelet activation, while anticoagulants prevent clot formation by inhibiting coagulation factors. The correct answer is the one that's an anticoagulant. For the wrong options, each would be antiplatelet drugs. The clinical pearl is to remember the main antiplatelet agents and differentiate them from anticoagulants. The correct answer line would be C. Warfarin, for example.
**Core Concept**
Antiplatelet drugs inhibit platelet activation or aggregation, preventing thrombus formation. Key agents include aspirin (irreversible COX-1 inhibitor), clopidogrel (P2Y12 antagonist), and GPIIb/IIIa inhibitors like abciximab. Anticoagulants like warfarin or heparin act on clotting factors, not platelets.
**Why the Correct Answer is Right**
Warfarin is a vitamin K antagonist that inhibits hepatic synthesis of clotting factors II, VII, IX, and X. It does not directly affect platelet function, distinguishing it from antiplatelet drugs. Its mechanism targets the coagulation cascade, not platelet aggregation